Table 3 Detailed information on patients with secondary involvement of breast through lymphomas.
From: Clinical and pathological features of lymphomas in the breast: a comprehensive multicentric study
Age at diagnosis | Range 20–83 years (mean 61.9) | |
|---|---|---|
Presentation | Palpation finding | 14 (35.0%) |
PET-positivity in the breast | 6 (15.0%) | |
Incidental finding at mammography | 1 (2.5%) | |
Skin erythema | 1 (2.5%) | |
No information | 18 (45.0%) | |
Radiology findings | BIRADS 3 | 1 (2.5%) |
BIRADS 4 | 3 (7.5%) | |
Metabolic active finding in PET | 6 (15.0%) | |
No specific information | 30 (75.0%) | |
Histology | Follicular lymphoma | 15 (37.5%) |
Extra-nodal marginal zone lymphoma | 8 (20.0%) | |
Chronic lymphocytic leukemia | 6 (15.0%) | |
DLBCL NOS | 4 (10.0%) | |
Extra-nodal NK/T-cell lymphoma | 2 (5.0%) | |
Splenic marginal zone lymphoma | 1 (2.5%) | |
High-grade B-cell lymphoma, double hit | 1 (2.5%) | |
Classic Hodgkin Lymphoma | 1 (2.5%) | |
Mantle cell Lymphoma | 1 (2.5%) | |
B lymphoblastic leukemia/lymphoma | 1 (2.5%) | |
